Evidence map›Paper›PMID 35008631›Full record

ReviewInternational journal of molecular sciences2021

Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease.

Vivian Naa Amua Wellington, Vijaya Lakshmi Sundaram, Soudamani Singh, Uma Sundaram

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Vitamin DApplied microbiology and biotechnology · 2026
    Review
  3. Review
  4. Article
  5. Vitamin DFrontiers in immunology · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Role of in vitamin D in irritable bowel syndrome.World journal of clinical cases · 2023
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vivian Naa Amua WellingtonDepartment of Clinical and Translational Sciences, Marshall University, Huntington, WV 25755, USA.
Vijaya Lakshmi SundaramDepartment of Clinical and Translational Sciences, Marshall University, Huntington, WV 25755, USA.
Soudamani SinghDepartment of Clinical and Translational Sciences, Marshall University, Huntington, WV 25755, USA.ORCID 0000-0001-6689-9942
Uma SundaramDepartment of Clinical and Translational Sciences, Marshall University, Huntington, WV 25755, USA.ORCID 0000-0002-9322-6740
Marshall University · US

Funding

Regulation of Tight Junction Molecular Composition by Na/K-ATPaseP20GM121299 · NIGMS · MARSHALL UNIVERSITY · PI HAYNES, JENNIFER · 2018 to 2022
$10.6M
NIH HHS DK067420NIH HHS DK108054NIH HHS P20GM121299United States Department of Veterans Affairs BX003443
6 · The paper itself

Abstract

Gastrointestinal health is influenced by the functional genes and metabolites generated by the human microbiome. As the volume of current biomedical and translational research indicates, the importance and impact of this ecosystem of microorganisms, especially those comprising the gut microbiome on human health, has become increasingly apparent. Changes to the gut microbiome are associated with inflammatory bowel disease (IBD), which is characterized by persistent intestinal inflammation. Furthermore, the lifetime dietary choices of their host may positively or negatively affect both the gut microbiome and its impact on IBD. As such, "anti-inflammatory" dietary supplements, their impact, and mechanisms in restoring gut microbiota homeostasis during IBD is an area of intensive research. Dietary supplementation may represent an important adjuvant treatment avenue for limiting intestinal inflammation in IBD. Overall, this review addresses the development of the gut microbiome, the significance of the gut microbiome in IBD, and the use of dietary supplements such as vitamin D, fish oil, and resveratrol in the mitigation of IBD-associated gut dysbiosis and intestinal inflammation.

Indexed as

Dietary SupplementsGastrointestinal MicrobiomeAnimalsFish OilsHumansInflammatory Bowel DiseasesResveratrolVitamin DFish OilsResveratrolVitamin Ddietary supplementsfish oilgut microbiomeIBDresveratrolvitamin D

Identifiers

PMID35008631
PMCPMC8745446
OpenAlexW4200168240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.